Last $128.66 USD
Change Today -0.52 / -0.40%
Volume 399.7K
As of 8:04 PM 04/17/14 All times are local (Market data is delayed by at least 15 minutes).

cooper cos inc/the (COO) Snapshot

Previous Close
Day High
Day Low
52 Week High
03/7/14 - $145.34
52 Week Low
04/19/13 - $104.24
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for COOPER COS INC/THE (COO)

cooper cos inc/the (COO) Related Bloomberg News

View More Bloomberg News

cooper cos inc/the (COO) Related Businessweek News

View More BusinessWeek News

cooper cos inc/the (COO) Details

The Cooper Companies, Inc. operates as a medical device company worldwide. The company develops, manufactures, and markets a range of contact lenses, including spherical lenses and toric and multifocal lenses that correct near and farsightedness, as well as address various complex visual defects, such as astigmatism and presbyopia. It also offers medical devices, diagnostic products, and surgical instruments and accessories for healthcare professionals and institutions to support healthcare delivery to women in hospitals, clinician offices, and fertility clinics. The company markets its products through field sales representatives, independent agents, and distributors. The Cooper Companies, Inc. was founded in 1980 and is headquartered in Pleasanton, California.

8,000 Employees
Last Reported Date: 12/20/13
Founded in 1980

cooper cos inc/the (COO) Top Compensated Officers

Chief Executive Officer, President, Non-Indep...
Total Annual Compensation: $1.0M
Chief Financial Officer, Chief Risk Officer a...
Total Annual Compensation: $418.3K
Chief Operating Officer, Executive Vice Presi...
Total Annual Compensation: $468.9K
Chief Administrative Officer, Chief Governanc...
Total Annual Compensation: $482.6K
Chief Strategic Officer and Vice President
Total Annual Compensation: $426.5K
Compensation as of Fiscal Year 2013.

cooper cos inc/the (COO) Key Developments

The Cooper Companies Inc. Reports Unaudited Consolidated Earnings Results for the First Quarter Ended December 31, 2013; Revises Earnings Guidance for Fiscal Year 2014

The Cooper Companies Inc. reported unaudited consolidated earnings results for the first quarter ended December 31, 2013. Net sales were $405 million against $380 million last year. Operating income was $81.6 million against $68.8 million last year. Income before income taxes was $79.5 million against $81 million last year. Net income attributable to Cooper stockholders was $71.8 million or $1.47 per diluted share against $74.7 million or $1.50 per diluted share last year. Cash provided by operations was $68.6 million. Capital expenditures were $61.0 million and insurance recovery of $1.4 million, resulted in free cash flow of $9.0 million. Non-GAAP EPS was $1.47, up 24 cents or 20% year over year. The company revised earnings guidance for fiscal year 2014. Total revenues are expected to be in the range of $1,685 million to $1,725 million against previous guidance range of $1,675 million to $1,735 million. GAAP and non-GAAP EPS is expected to be in the range of $6.75 to $7.00 against previous guidance range of $6.70 to $7.00. Gross margin percentage still expected to be around 65%. Operating margin is expected to be around 22% and the effective tax rate in the range of 8.5% to 10.5%. In addition, free cash flow and capex are still expected to be greater than $200 million.

Cooper Companies Mulls Acquisitions

The Cooper Companies Inc. (NYSE:COO) is seeking acquisitions. Bob Weiss, President and Chief Executive Officer of Cooper, said, "We are dedicated to the strategy and will continue tuck-in and non US acquisitions to leverage this [physical] structure and products. Also, given the considerable amount of free cash flow we generate, we will continue to look for tuck-in acquisitions and geographic expansion opportunities like [Oreshio] in our two businesses. The key requirements however is that each of the acquisitions must exceed our minimum investment hurdle rates. Each must achieve over time a hurdle rate that exceeds 10%."

The Cooper Companies Inc. Presents at Barclays Capital 2014 Global Healthcare Conference, Mar-11-2014 01:30 PM

The Cooper Companies Inc. Presents at Barclays Capital 2014 Global Healthcare Conference, Mar-11-2014 01:30 PM. Venue: Loews Miami Beach Hotel, Miami, Florida, United States. Speakers: Gregory W. Matz, Chief Financial Officer, Chief Risk Officer and Vice President.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
COO:US $128.66 USD -0.52

COO Competitors

Market data is delayed at least 15 minutes.

Company Last Change
IDEXX Laboratories Inc $117.94 USD -0.30
MEDNAX Inc $60.45 USD +0.01
PerkinElmer Inc $44.27 USD +0.08
ResMed Inc $47.44 USD +0.95
Teleflex Inc $101.84 USD -0.34
View Industry Companies

Industry Analysis


Industry Average

Valuation COO Industry Range
Price/Earnings 21.7x
Price/Sales 3.8x
Price/Book 2.5x
Price/Cash Flow 19.0x
TEV/Sales 3.6x

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact COOPER COS INC/THE, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at